Mutang Chun Pian (木糖醇片)木糖醇片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 华润双鹤药业股份有限公司Chinese legal name: 华润双鹤药业股份有限公司
主要成分Active Ingredients
- 木糖醇Mutang Chun
药物知识说明
木糖醇是一种在国家药监局注册认定的药品。该药品含有木糖醇-1224f1fb等成分。
该药品关联的活性成分包括：木糖醇Mutang Chun。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：华润双鹤药业股份有限公司Chinese legal name: 华润双鹤药业股份有限公司。
您可以探索含有相同成分的其他药品：木糖醇-1224f1fb成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 木糖醇片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 木糖醇Mutang Chun.
Manufacturers recorded for this product: 华润双鹤药业股份有限公司Chinese legal name: 华润双鹤药业股份有限公司.
Explore other medicines containing the same ingredient: 木糖醇 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 木糖醇片Recorded Chinese name: 木糖醇片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 5g。5 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 华润双鹤药业股份有限公司Chinese legal name: 华润双鹤药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H11022384
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H11022384
Manufacturer
Chinese legal name: 华润双鹤药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H11022384
生产企业
华润双鹤药业股份有限公司(国产)
适应症
用于糖尿病患者的糖代用品。
用法用量
口服，一次10克，一日3～4次。嚼碎服，含化服或调和于饮食中服用。
不良反应
初服时可有肠鸣、腹胀、腹泻等症状。适当减少剂量，可减少不良反应。
禁忌
胰岛素诱发的低血糖患者禁用。
注意事项
1.儿童用量请咨询医师或药师。
2.本品不宜过量服用。
3.对本品过敏者禁用，过敏体质者慎用。
4.本品性状发生改变时禁止使用。
5.请将本品放在儿童不能接触的地方。
6.儿童必须在成人监护下使用。
7.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
密闭，遮光，在阴凉干燥处保存.
规格
5g。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.